Nobel prize winner Paul Ehrlich in 1900 was the first to come up with the concept of the magic bullet—a drug to specifically target a disease-causing factor. At the time, research into antibodies was not sophisticated enough to allow them to fulfill that role, but a lot of progress has been made since then. This illustrated timeline provides a look back at the major innovations that allowed antibody therapeutics to become the multi-billion dollar industry that it is today. Keystone research discoveries and drug approvals from the first images of an antibody's molecular structure in 1959 to the release of the first antibody biosimilar in 2016 are highlighted.
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
Please enter the e-mail address you would like to be contacted at.